Other ways to search: Events Calendar | UTHSC

StreptAnova® Phase 1 clinical trial to start: Vaccine designed to prevent Streptococcus pyogenes infections


StreptAnova® was invented by James B. Dale, M.D., Chief of the Division of Infectious Diseases, and Gene H. Stollerman, M.D., Endowed Professor in Medicine at the University of Tennessee Health Science Center (UTHSC), and Research Scientist at the Memphis Veterans Affairs Medical Center. It is being commercialized jointly by PREVENT and Vaxent, a company founded by Dr. Dale.

Top Publishers